10-K Filing
Filing Information
| Form Type | 10-K |
| Accession Number | 0000950170-25-029545 |
| Period End Date | 20241231 |
| Filing Date | 20250228 |
| Fiscal Year | 2024 |
| Fiscal Period | FY |
| XBRL Instance | slno-20241231_htm.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
142 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Preferred stock, par value |
PreferredStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Preferred stock, par value |
PreferredStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Preferred stock, par value |
PreferredStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Preferred stock, par value |
PreferredStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Preferred stock, shares authorized |
PreferredStockSharesAuthorized
|
10.00M | shares | Point-in-time |
| Preferred stock, shares authorized |
PreferredStockSharesAuthorized
|
10.00M | shares | Point-in-time |
| Preferred stock, shares authorized |
PreferredStockSharesAuthorized
|
10.00M | shares | Point-in-time |
| Preferred stock, shares authorized |
PreferredStockSharesAuthorized
|
10.00M | shares | Point-in-time |
| Preferred stock, shares issued |
PreferredStockSharesIssued
|
0.00 | shares | Point-in-time |
| Preferred stock, shares issued |
PreferredStockSharesIssued
|
0.00 | shares | Point-in-time |
| Preferred stock, shares issued |
PreferredStockSharesIssued
|
0.00 | shares | Point-in-time |
| Preferred stock, shares issued |
PreferredStockSharesIssued
|
0.00 | shares | Point-in-time |
| Preferred stock, shares outstanding |
PreferredStockSharesOutstanding
|
0.00 | shares | Point-in-time |
| Preferred stock, shares outstanding |
PreferredStockSharesOutstanding
|
0.00 | shares | Point-in-time |
| Preferred stock, shares outstanding |
PreferredStockSharesOutstanding
|
0.00 | shares | Point-in-time |
| Preferred stock, shares outstanding |
PreferredStockSharesOutstanding
|
0.00 | shares | Point-in-time |
| Common stock, par value (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Common stock, par value (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Common stock, par value (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Common stock, par value (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Common stock, shares authorized |
CommonStockSharesAuthorized
|
100.00M | shares | Point-in-time |
| Common stock, shares authorized |
CommonStockSharesAuthorized
|
100.00M | shares | Point-in-time |
| Common stock, shares authorized |
CommonStockSharesAuthorized
|
100.00M | shares | Point-in-time |
| Common stock, shares authorized |
CommonStockSharesAuthorized
|
100.00M | shares | Point-in-time |
| Common stock, shares issued |
CommonStockSharesIssued
|
45.70M | shares | Point-in-time |
| Common stock, shares issued |
CommonStockSharesIssued
|
45.70M | shares | Point-in-time |
| Common stock, shares issued |
CommonStockSharesIssued
|
31.68M | shares | Point-in-time |
| Common stock, shares issued |
CommonStockSharesIssued
|
31.68M | shares | Point-in-time |
| Common stock, shares outstanding |
CommonStockSharesOutstanding
|
31.68M | shares | Point-in-time |
| Common stock, shares outstanding |
CommonStockSharesOutstanding
|
31.68M | shares | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$87.93M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$87.93M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$169.68M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$169.68M | USD | Point-in-time |
| Common stock, shares outstanding |
CommonStockSharesOutstanding
|
45.70M | shares | Point-in-time |
| Common stock, shares outstanding |
CommonStockSharesOutstanding
|
45.70M | shares | Point-in-time |
| Marketable securities |
MarketableSecuritiesCurrent
|
$203.51M | USD | Point-in-time |
| Marketable securities |
MarketableSecuritiesCurrent
|
$203.51M | USD | Point-in-time |
| Prepaid expenses and other current assets |
PrepaidExpenseAndOtherAssetsCurrent
|
$2.45M | USD | Point-in-time |
| Prepaid expenses and other current assets |
PrepaidExpenseAndOtherAssetsCurrent
|
$2.45M | USD | Point-in-time |
| Prepaid expenses and other current assets |
PrepaidExpenseAndOtherAssetsCurrent
|
$1.68M | USD | Point-in-time |
| Prepaid expenses and other current assets |
PrepaidExpenseAndOtherAssetsCurrent
|
$1.68M | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$293.89M | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$293.89M | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$171.36M | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$171.36M | USD | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$12.00K | USD | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$12.00K | USD | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$186.00K | USD | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$186.00K | USD | Point-in-time |
| Operating lease right-of-use assets |
OperatingLeaseRightOfUseAsset
|
$407.00K | USD | Point-in-time |
| Operating lease right-of-use assets |
OperatingLeaseRightOfUseAsset
|
$407.00K | USD | Point-in-time |
| Operating lease right-of-use assets |
OperatingLeaseRightOfUseAsset
|
$2.80M | USD | Point-in-time |
| Operating lease right-of-use assets |
OperatingLeaseRightOfUseAsset
|
$2.80M | USD | Point-in-time |
| Intangible assets, net |
IntangibleAssetsNetExcludingGoodwill
|
$6.80M | USD | Point-in-time |
| Intangible assets, net |
IntangibleAssetsNetExcludingGoodwill
|
$6.80M | USD | Point-in-time |
| Intangible assets, net |
IntangibleAssetsNetExcludingGoodwill
|
$8.75M | USD | Point-in-time |
| Intangible assets, net |
IntangibleAssetsNetExcludingGoodwill
|
$8.75M | USD | Point-in-time |
| Long-term marketable securities |
MarketableSecuritiesNoncurrent
|
$27.21M | USD | Point-in-time |
| Long-term marketable securities |
MarketableSecuritiesNoncurrent
|
$27.21M | USD | Point-in-time |
| Other long-term assets |
OtherAssetsNoncurrent
|
$83.00K | USD | Point-in-time |
| Other long-term assets |
OtherAssetsNoncurrent
|
$83.00K | USD | Point-in-time |
| Other long-term assets |
OtherAssetsNoncurrent
|
$165.00K | USD | Point-in-time |
| Other long-term assets |
OtherAssetsNoncurrent
|
$165.00K | USD | Point-in-time |
| Total assets |
Assets
|
$330.97M | USD | Point-in-time |
| Total assets |
Assets
|
$330.97M | USD | Point-in-time |
| Total assets |
Assets
|
$180.69M | USD | Point-in-time |
| Total assets |
Assets
|
$180.69M | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$3.15M | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$3.15M | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$8.88M | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$8.88M | USD | Point-in-time |
| Accrued compensation |
EmployeeRelatedLiabilitiesCurrent
|
$3.13M | USD | Point-in-time |
| Accrued compensation |
EmployeeRelatedLiabilitiesCurrent
|
$3.13M | USD | Point-in-time |
| Accrued compensation |
EmployeeRelatedLiabilitiesCurrent
|
$4.78M | USD | Point-in-time |
| Accrued compensation |
EmployeeRelatedLiabilitiesCurrent
|
$4.78M | USD | Point-in-time |
| Accrued clinical trial site costs |
AccruedClinicalTrialCostsCurrent
|
$3.39M | USD | Point-in-time |
| Accrued clinical trial site costs |
AccruedClinicalTrialCostsCurrent
|
$3.39M | USD | Point-in-time |
| Accrued clinical trial site costs |
AccruedClinicalTrialCostsCurrent
|
$1.83M | USD | Point-in-time |
| Accrued clinical trial site costs |
AccruedClinicalTrialCostsCurrent
|
$1.83M | USD | Point-in-time |
| Operating lease liabilities |
OperatingLeaseLiabilityCurrent
|
$273.00K | USD | Point-in-time |
| Operating lease liabilities |
OperatingLeaseLiabilityCurrent
|
$273.00K | USD | Point-in-time |
| Operating lease liabilities |
OperatingLeaseLiabilityCurrent
|
$526.00K | USD | Point-in-time |
| Operating lease liabilities |
OperatingLeaseLiabilityCurrent
|
$526.00K | USD | Point-in-time |
| Other current liabilities |
OtherLiabilitiesCurrent
|
$2.74M | USD | Point-in-time |
| Other current liabilities |
OtherLiabilitiesCurrent
|
$2.74M | USD | Point-in-time |
| Other current liabilities |
OtherLiabilitiesCurrent
|
$1.55M | USD | Point-in-time |
| Other current liabilities |
OtherLiabilitiesCurrent
|
$1.55M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$18.75M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$18.75M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$11.51M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$11.51M | USD | Point-in-time |
| Contingent liability for Essentialis purchase price |
AssetAcquisitionContingentConsiderationLiabilityNoncurrent
|
$11.55M | USD | Point-in-time |
| Contingent liability for Essentialis purchase price |
AssetAcquisitionContingentConsiderationLiabilityNoncurrent
|
$11.55M | USD | Point-in-time |
| Contingent liability for Essentialis purchase price |
AssetAcquisitionContingentConsiderationLiabilityNoncurrent
|
$14.79M | USD | Point-in-time |
| Contingent liability for Essentialis purchase price |
AssetAcquisitionContingentConsiderationLiabilityNoncurrent
|
$14.79M | USD | Point-in-time |
| Long-term debt, net |
LongTermDebtNoncurrent
|
$49.83M | USD | Point-in-time |
| Long-term debt, net |
LongTermDebtNoncurrent
|
$49.83M | USD | Point-in-time |
| Long-term lease liabilities |
OperatingLeaseLiabilityNoncurrent
|
$2.47M | USD | Point-in-time |
| Long-term lease liabilities |
OperatingLeaseLiabilityNoncurrent
|
$2.47M | USD | Point-in-time |
| Long-term lease liabilities |
OperatingLeaseLiabilityNoncurrent
|
$130.00K | USD | Point-in-time |
| Long-term lease liabilities |
OperatingLeaseLiabilityNoncurrent
|
$130.00K | USD | Point-in-time |
| Other Liabilities, Noncurrent |
OtherLiabilitiesNoncurrent
|
$21.00K | USD | Point-in-time |
| Other Liabilities, Noncurrent |
OtherLiabilitiesNoncurrent
|
$21.00K | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$23.18M | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$23.18M | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$85.86M | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$85.86M | USD | Point-in-time |
| Commitments and contingencies (Note 7) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Commitments and contingencies (Note 7) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Commitments and contingencies (Note 7) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Commitments and contingencies (Note 7) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Preferred stock, $0.001 par value; 10,000,000 shares authorized, no shares issued and outstanding |
PreferredStockValue
|
- | USD | Point-in-time |
| Preferred stock, $0.001 par value; 10,000,000 shares authorized, no shares issued and outstanding |
PreferredStockValue
|
- | USD | Point-in-time |
| Preferred stock, $0.001 par value; 10,000,000 shares authorized, no shares issued and outstanding |
PreferredStockValue
|
- | USD | Point-in-time |
| Preferred stock, $0.001 par value; 10,000,000 shares authorized, no shares issued and outstanding |
PreferredStockValue
|
- | USD | Point-in-time |
| Common stock, $0.001 par value, 100,000,000 shares authorized, 45,703,811 and 31,678,159 shares issued and outstanding at December 31, 2024 and 2023, respectively |
CommonStockValue
|
$32.00K | USD | Point-in-time |
| Common stock, $0.001 par value, 100,000,000 shares authorized, 45,703,811 and 31,678,159 shares issued and outstanding at December 31, 2024 and 2023, respectively |
CommonStockValue
|
$32.00K | USD | Point-in-time |
| Common stock, $0.001 par value, 100,000,000 shares authorized, 45,703,811 and 31,678,159 shares issued and outstanding at December 31, 2024 and 2023, respectively |
CommonStockValue
|
$46.00K | USD | Point-in-time |
| Common stock, $0.001 par value, 100,000,000 shares authorized, 45,703,811 and 31,678,159 shares issued and outstanding at December 31, 2024 and 2023, respectively |
CommonStockValue
|
$46.00K | USD | Point-in-time |
| Additional paid-in-capital |
AdditionalPaidInCapitalCommonStock
|
$696.97M | USD | Point-in-time |
| Additional paid-in-capital |
AdditionalPaidInCapitalCommonStock
|
$696.97M | USD | Point-in-time |
| Additional paid-in-capital |
AdditionalPaidInCapitalCommonStock
|
$433.88M | USD | Point-in-time |
| Additional paid-in-capital |
AdditionalPaidInCapitalCommonStock
|
$433.88M | USD | Point-in-time |
| Accumulated other comprehensive gain |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$361.00K | USD | Point-in-time |
| Accumulated other comprehensive gain |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$361.00K | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-452.26M | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-452.26M | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-276.41M | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-276.41M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$17.79M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$17.79M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$157.51M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$157.51M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$10.35M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$10.35M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$245.11M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$245.11M | USD | Point-in-time |
| Total liabilities and stockholders'equity |
LiabilitiesAndStockholdersEquity
|
$180.69M | USD | Point-in-time |
| Total liabilities and stockholders'equity |
LiabilitiesAndStockholdersEquity
|
$180.69M | USD | Point-in-time |
| Total liabilities and stockholders'equity |
LiabilitiesAndStockholdersEquity
|
$330.97M | USD | Point-in-time |
| Total liabilities and stockholders'equity |
LiabilitiesAndStockholdersEquity
|
$330.97M | USD | Point-in-time |
Income Statement
96 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Research and development |
ResearchAndDevelopmentExpense
|
$25.19M | USD | Annual |
| Research and development |
ResearchAndDevelopmentExpense
|
$25.19M | USD | Annual |
| Research and development |
ResearchAndDevelopmentExpense
|
$15.27M | USD | Annual |
| Research and development |
ResearchAndDevelopmentExpense
|
$15.27M | USD | Annual |
| Research and development |
ResearchAndDevelopmentExpense
|
$78.57M | USD | Annual |
| Research and development |
ResearchAndDevelopmentExpense
|
$78.57M | USD | Annual |
| General and administrative |
GeneralAndAdministrativeExpense
|
$105.86M | USD | Annual |
| General and administrative |
GeneralAndAdministrativeExpense
|
$105.86M | USD | Annual |
| General and administrative |
GeneralAndAdministrativeExpense
|
$9.84M | USD | Annual |
| General and administrative |
GeneralAndAdministrativeExpense
|
$9.84M | USD | Annual |
| General and administrative |
GeneralAndAdministrativeExpense
|
$13.48M | USD | Annual |
| General and administrative |
GeneralAndAdministrativeExpense
|
$13.48M | USD | Annual |
| Change in fair value of contingent consideration |
AssetAcquisitionContingentConsiderationChangeInFairValue
|
$2.71M | USD | Annual |
| Change in fair value of contingent consideration |
AssetAcquisitionContingentConsiderationChangeInFairValue
|
$2.71M | USD | Annual |
| Change in fair value of contingent consideration |
AssetAcquisitionContingentConsiderationChangeInFairValue
|
$3.24M | USD | Annual |
| Change in fair value of contingent consideration |
AssetAcquisitionContingentConsiderationChangeInFairValue
|
$3.24M | USD | Annual |
| Change in fair value of contingent consideration |
AssetAcquisitionContingentConsiderationChangeInFairValue
|
$-712.00K | USD | Annual |
| Change in fair value of contingent consideration |
AssetAcquisitionContingentConsiderationChangeInFairValue
|
$-712.00K | USD | Annual |
| Total operating expenses |
OperatingExpenses
|
$187.67M | USD | Annual |
| Total operating expenses |
OperatingExpenses
|
$187.67M | USD | Annual |
| Total operating expenses |
OperatingExpenses
|
$24.40M | USD | Annual |
| Total operating expenses |
OperatingExpenses
|
$24.40M | USD | Annual |
| Total operating expenses |
OperatingExpenses
|
$41.38M | USD | Annual |
| Total operating expenses |
OperatingExpenses
|
$41.38M | USD | Annual |
| Operating loss |
OperatingIncomeLoss
|
$-41.38M | USD | Annual |
| Operating loss |
OperatingIncomeLoss
|
$-41.38M | USD | Annual |
| Operating loss |
OperatingIncomeLoss
|
$-24.40M | USD | Annual |
| Operating loss |
OperatingIncomeLoss
|
$-24.40M | USD | Annual |
| Operating loss |
OperatingIncomeLoss
|
$-187.67M | USD | Annual |
| Operating loss |
OperatingIncomeLoss
|
$-187.67M | USD | Annual |
| Change in fair value of warrant liability |
FairValueAdjustmentOfWarrants
|
$182.00K | USD | Annual |
| Change in fair value of warrant liability |
FairValueAdjustmentOfWarrants
|
$182.00K | USD | Annual |
| Change in fair value of warrant liability |
FairValueAdjustmentOfWarrants
|
$-30.00K | USD | Annual |
| Change in fair value of warrant liability |
FairValueAdjustmentOfWarrants
|
$-30.00K | USD | Annual |
| Change in fair value of warrant liability |
FairValueAdjustmentOfWarrants
|
- | USD | Annual |
| Change in fair value of warrant liability |
FairValueAdjustmentOfWarrants
|
- | USD | Annual |
| Interest income, net |
InvestmentIncomeInterest
|
$300.00K | USD | Annual |
| Interest income, net |
InvestmentIncomeInterest
|
$300.00K | USD | Annual |
| Interest income, net |
InvestmentIncomeInterest
|
$12.05M | USD | Annual |
| Interest income, net |
InvestmentIncomeInterest
|
$12.05M | USD | Annual |
| Interest income, net |
InvestmentIncomeInterest
|
$2.58M | USD | Annual |
| Interest income, net |
InvestmentIncomeInterest
|
$2.58M | USD | Annual |
| Interest expense |
InterestExpenseNonoperating
|
- | USD | Annual |
| Interest expense |
InterestExpenseNonoperating
|
- | USD | Annual |
| Interest expense |
InterestExpenseNonoperating
|
$231.00K | USD | Annual |
| Interest expense |
InterestExpenseNonoperating
|
$231.00K | USD | Annual |
| Interest expense |
InterestExpenseNonoperating
|
- | USD | Annual |
| Interest expense |
InterestExpenseNonoperating
|
- | USD | Annual |
| Total other income (expense), net |
NonoperatingIncomeExpense
|
$2.40M | USD | Annual |
| Total other income (expense), net |
NonoperatingIncomeExpense
|
$2.40M | USD | Annual |
| Total other income (expense), net |
NonoperatingIncomeExpense
|
$11.82M | USD | Annual |
| Total other income (expense), net |
NonoperatingIncomeExpense
|
$11.82M | USD | Annual |
| Total other income (expense), net |
NonoperatingIncomeExpense
|
$330.00K | USD | Annual |
| Total other income (expense), net |
NonoperatingIncomeExpense
|
$330.00K | USD | Annual |
| Net loss |
NetIncomeLoss
|
$-175.85M | USD | Annual |
| Net loss |
NetIncomeLoss
|
$-175.85M | USD | Annual |
| Net loss |
NetIncomeLoss
|
$-24.07M | USD | Annual |
| Net loss |
NetIncomeLoss
|
$-24.07M | USD | Annual |
| Net loss |
NetIncomeLoss
|
$-38.99M | USD | Annual |
| Net loss |
NetIncomeLoss
|
$-38.99M | USD | Annual |
| Net unrealized gain on marketable securities |
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
- | USD | Annual |
| Net unrealized gain on marketable securities |
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
- | USD | Annual |
| Net unrealized gain on marketable securities |
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
- | USD | Annual |
| Net unrealized gain on marketable securities |
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
- | USD | Annual |
| Net unrealized gain on marketable securities |
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
$361.00K | USD | Annual |
| Net unrealized gain on marketable securities |
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
$361.00K | USD | Annual |
| Total comprehensive loss |
ComprehensiveIncomeNetOfTax
|
$-175.49M | USD | Annual |
| Total comprehensive loss |
ComprehensiveIncomeNetOfTax
|
$-175.49M | USD | Annual |
| Total comprehensive loss |
ComprehensiveIncomeNetOfTax
|
$-38.99M | USD | Annual |
| Total comprehensive loss |
ComprehensiveIncomeNetOfTax
|
$-38.99M | USD | Annual |
| Total comprehensive loss |
ComprehensiveIncomeNetOfTax
|
$-24.07M | USD | Annual |
| Total comprehensive loss |
ComprehensiveIncomeNetOfTax
|
$-24.07M | USD | Annual |
| Net loss per common share basic |
EarningsPerShareBasic
|
$-2.87 | USD | Annual |
| Net loss per common share basic |
EarningsPerShareBasic
|
$-2.87 | USD | Annual |
| Net loss per common share basic |
EarningsPerShareBasic
|
$-4.38 | USD | Annual |
| Net loss per common share basic |
EarningsPerShareBasic
|
$-4.38 | USD | Annual |
| Net loss per common share basic |
EarningsPerShareBasic
|
$-2.36 | USD | Annual |
| Net loss per common share basic |
EarningsPerShareBasic
|
$-2.36 | USD | Annual |
| Net loss per common share diluted |
EarningsPerShareDiluted
|
$-2.87 | USD | Annual |
| Net loss per common share diluted |
EarningsPerShareDiluted
|
$-2.87 | USD | Annual |
| Net loss per common share diluted |
EarningsPerShareDiluted
|
$-4.38 | USD | Annual |
| Net loss per common share diluted |
EarningsPerShareDiluted
|
$-4.38 | USD | Annual |
| Net loss per common share diluted |
EarningsPerShareDiluted
|
$-2.36 | USD | Annual |
| Net loss per common share diluted |
EarningsPerShareDiluted
|
$-2.36 | USD | Annual |
| Weighted-average common shares outstanding used to calculate basic net loss per common share |
WeightedAverageNumberOfSharesOutstandingBasic
|
8.40M | shares | Annual |
| Weighted-average common shares outstanding used to calculate basic net loss per common share |
WeightedAverageNumberOfSharesOutstandingBasic
|
8.40M | shares | Annual |
| Weighted-average common shares outstanding used to calculate basic net loss per common share |
WeightedAverageNumberOfSharesOutstandingBasic
|
40.18M | shares | Annual |
| Weighted-average common shares outstanding used to calculate basic net loss per common share |
WeightedAverageNumberOfSharesOutstandingBasic
|
40.18M | shares | Annual |
| Weighted-average common shares outstanding used to calculate basic net loss per common share |
WeightedAverageNumberOfSharesOutstandingBasic
|
16.49M | shares | Annual |
| Weighted-average common shares outstanding used to calculate basic net loss per common share |
WeightedAverageNumberOfSharesOutstandingBasic
|
16.49M | shares | Annual |
| Weighted-average common shares outstanding used to calculate diluted net loss per common share |
WeightedAverageNumberOfDilutedSharesOutstanding
|
16.49M | shares | Annual |
| Weighted-average common shares outstanding used to calculate diluted net loss per common share |
WeightedAverageNumberOfDilutedSharesOutstanding
|
16.49M | shares | Annual |
| Weighted-average common shares outstanding used to calculate diluted net loss per common share |
WeightedAverageNumberOfDilutedSharesOutstanding
|
40.18M | shares | Annual |
| Weighted-average common shares outstanding used to calculate diluted net loss per common share |
WeightedAverageNumberOfDilutedSharesOutstanding
|
40.18M | shares | Annual |
| Weighted-average common shares outstanding used to calculate diluted net loss per common share |
WeightedAverageNumberOfDilutedSharesOutstanding
|
8.40M | shares | Annual |
| Weighted-average common shares outstanding used to calculate diluted net loss per common share |
WeightedAverageNumberOfDilutedSharesOutstanding
|
8.40M | shares | Annual |
Cash Flow Statement
196 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net loss |
ProfitLoss
|
$-24.07M | USD | Annual |
| Net loss |
ProfitLoss
|
$-24.07M | USD | Annual |
| Net loss |
ProfitLoss
|
$-38.99M | USD | Annual |
| Net loss |
ProfitLoss
|
$-38.99M | USD | Annual |
| Net loss |
ProfitLoss
|
$-175.85M | USD | Annual |
| Net loss |
ProfitLoss
|
$-175.85M | USD | Annual |
| Depreciation and amortization |
DepreciationAndAmortization
|
$1.96M | USD | Annual |
| Depreciation and amortization |
DepreciationAndAmortization
|
$1.96M | USD | Annual |
| Depreciation and amortization |
DepreciationAndAmortization
|
$1.99M | USD | Annual |
| Depreciation and amortization |
DepreciationAndAmortization
|
$1.99M | USD | Annual |
| Depreciation and amortization |
DepreciationAndAmortization
|
$1.96M | USD | Annual |
| Depreciation and amortization |
DepreciationAndAmortization
|
$1.96M | USD | Annual |
| Accretion of premium/discount on marketable securities |
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
- | USD | Annual |
| Accretion of premium/discount on marketable securities |
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
- | USD | Annual |
| Accretion of premium/discount on marketable securities |
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
- | USD | Annual |
| Accretion of premium/discount on marketable securities |
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
- | USD | Annual |
| Accretion of premium/discount on marketable securities |
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
$4.89M | USD | Annual |
| Accretion of premium/discount on marketable securities |
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
$4.89M | USD | Annual |
| Noncash lease expense |
NoncashLeaseExpense
|
$444.00K | USD | Annual |
| Noncash lease expense |
NoncashLeaseExpense
|
$444.00K | USD | Annual |
| Noncash lease expense |
NoncashLeaseExpense
|
$321.00K | USD | Annual |
| Noncash lease expense |
NoncashLeaseExpense
|
$321.00K | USD | Annual |
| Noncash lease expense |
NoncashLeaseExpense
|
$290.00K | USD | Annual |
| Noncash lease expense |
NoncashLeaseExpense
|
$290.00K | USD | Annual |
| Stock-based compensation expense |
ShareBasedCompensation
|
$99.96M | USD | Annual |
| Stock-based compensation expense |
ShareBasedCompensation
|
$99.96M | USD | Annual |
| Stock-based compensation expense |
ShareBasedCompensation
|
$2.53M | USD | Annual |
| Stock-based compensation expense |
ShareBasedCompensation
|
$2.53M | USD | Annual |
| Stock-based compensation expense |
ShareBasedCompensation
|
$5.95M | USD | Annual |
| Stock-based compensation expense |
ShareBasedCompensation
|
$5.95M | USD | Annual |
| Change in fair value of stock warrants |
FairValueAdjustmentOfWarrants
|
$182.00K | USD | Annual |
| Change in fair value of stock warrants |
FairValueAdjustmentOfWarrants
|
$182.00K | USD | Annual |
| Change in fair value of stock warrants |
FairValueAdjustmentOfWarrants
|
$-30.00K | USD | Annual |
| Change in fair value of stock warrants |
FairValueAdjustmentOfWarrants
|
$-30.00K | USD | Annual |
| Change in fair value of stock warrants |
FairValueAdjustmentOfWarrants
|
- | USD | Annual |
| Change in fair value of stock warrants |
FairValueAdjustmentOfWarrants
|
- | USD | Annual |
| Change in fair value of contingent consideration |
AssetAcquisitionContingentConsiderationChangeInFairValue
|
$2.71M | USD | Annual |
| Change in fair value of contingent consideration |
AssetAcquisitionContingentConsiderationChangeInFairValue
|
$2.71M | USD | Annual |
| Change in fair value of contingent consideration |
AssetAcquisitionContingentConsiderationChangeInFairValue
|
$3.24M | USD | Annual |
| Change in fair value of contingent consideration |
AssetAcquisitionContingentConsiderationChangeInFairValue
|
$3.24M | USD | Annual |
| Change in fair value of contingent consideration |
AssetAcquisitionContingentConsiderationChangeInFairValue
|
$-712.00K | USD | Annual |
| Change in fair value of contingent consideration |
AssetAcquisitionContingentConsiderationChangeInFairValue
|
$-712.00K | USD | Annual |
| Prepaid expenses, other current assets and other assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$837.00K | USD | Annual |
| Prepaid expenses, other current assets and other assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$837.00K | USD | Annual |
| Prepaid expenses, other current assets and other assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$-113.00K | USD | Annual |
| Prepaid expenses, other current assets and other assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$-113.00K | USD | Annual |
| Prepaid expenses, other current assets and other assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$750.00K | USD | Annual |
| Prepaid expenses, other current assets and other assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$750.00K | USD | Annual |
| Accounts payable |
IncreaseDecreaseInAccountsPayable
|
$5.67M | USD | Annual |
| Accounts payable |
IncreaseDecreaseInAccountsPayable
|
$5.67M | USD | Annual |
| Accounts payable |
IncreaseDecreaseInAccountsPayable
|
$-1.48M | USD | Annual |
| Accounts payable |
IncreaseDecreaseInAccountsPayable
|
$-1.48M | USD | Annual |
| Accounts payable |
IncreaseDecreaseInAccountsPayable
|
$1.37M | USD | Annual |
| Accounts payable |
IncreaseDecreaseInAccountsPayable
|
$1.37M | USD | Annual |
| Accrued compensation |
IncreaseDecreaseInEmployeeRelatedLiabilities
|
$1.64M | USD | Annual |
| Accrued compensation |
IncreaseDecreaseInEmployeeRelatedLiabilities
|
$1.64M | USD | Annual |
| Accrued compensation |
IncreaseDecreaseInEmployeeRelatedLiabilities
|
$1.46M | USD | Annual |
| Accrued compensation |
IncreaseDecreaseInEmployeeRelatedLiabilities
|
$1.46M | USD | Annual |
| Accrued compensation |
IncreaseDecreaseInEmployeeRelatedLiabilities
|
$947.00K | USD | Annual |
| Accrued compensation |
IncreaseDecreaseInEmployeeRelatedLiabilities
|
$947.00K | USD | Annual |
| Accrued clinical trial site costs |
IncreaseDecreaseInAccruedClinicalTrialSiteCosts
|
$-1.57M | USD | Annual |
| Accrued clinical trial site costs |
IncreaseDecreaseInAccruedClinicalTrialSiteCosts
|
$-1.57M | USD | Annual |
| Accrued clinical trial site costs |
IncreaseDecreaseInAccruedClinicalTrialSiteCosts
|
$171.00K | USD | Annual |
| Accrued clinical trial site costs |
IncreaseDecreaseInAccruedClinicalTrialSiteCosts
|
$171.00K | USD | Annual |
| Accrued clinical trial site costs |
IncreaseDecreaseInAccruedClinicalTrialSiteCosts
|
$-198.00K | USD | Annual |
| Accrued clinical trial site costs |
IncreaseDecreaseInAccruedClinicalTrialSiteCosts
|
$-198.00K | USD | Annual |
| Operating lease liabilities |
IncreaseDecreaseInOperatingLeaseLiabilities
|
$-309.00K | USD | Annual |
| Operating lease liabilities |
IncreaseDecreaseInOperatingLeaseLiabilities
|
$-309.00K | USD | Annual |
| Operating lease liabilities |
IncreaseDecreaseInOperatingLeaseLiabilities
|
$-183.00K | USD | Annual |
| Operating lease liabilities |
IncreaseDecreaseInOperatingLeaseLiabilities
|
$-183.00K | USD | Annual |
| Operating lease liabilities |
IncreaseDecreaseInOperatingLeaseLiabilities
|
$-302.00K | USD | Annual |
| Operating lease liabilities |
IncreaseDecreaseInOperatingLeaseLiabilities
|
$-302.00K | USD | Annual |
| Other liabilities |
IncreaseDecreaseInOtherOperatingLiabilities
|
$1.07M | USD | Annual |
| Other liabilities |
IncreaseDecreaseInOtherOperatingLiabilities
|
$1.07M | USD | Annual |
| Other liabilities |
IncreaseDecreaseInOtherOperatingLiabilities
|
$161.00K | USD | Annual |
| Other liabilities |
IncreaseDecreaseInOtherOperatingLiabilities
|
$161.00K | USD | Annual |
| Other liabilities |
IncreaseDecreaseInOtherOperatingLiabilities
|
$1.21M | USD | Annual |
| Other liabilities |
IncreaseDecreaseInOtherOperatingLiabilities
|
$1.21M | USD | Annual |
| Net cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-20.78M | USD | Annual |
| Net cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-20.78M | USD | Annual |
| Net cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-69.10M | USD | Annual |
| Net cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-69.10M | USD | Annual |
| Net cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-24.94M | USD | Annual |
| Net cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-24.94M | USD | Annual |
| Purchases of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
- | USD | Annual |
| Purchases of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
- | USD | Annual |
| Purchases of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$218.00K | USD | Annual |
| Purchases of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$218.00K | USD | Annual |
| Purchases of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$13.00K | USD | Annual |
| Purchases of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$13.00K | USD | Annual |
| Purchases of marketable securities |
PaymentsToAcquireMarketableSecurities
|
$356.46M | USD | Annual |
| Purchases of marketable securities |
PaymentsToAcquireMarketableSecurities
|
$356.46M | USD | Annual |
| Purchases of marketable securities |
PaymentsToAcquireMarketableSecurities
|
- | USD | Annual |
| Purchases of marketable securities |
PaymentsToAcquireMarketableSecurities
|
- | USD | Annual |
| Purchases of marketable securities |
PaymentsToAcquireMarketableSecurities
|
- | USD | Annual |
| Purchases of marketable securities |
PaymentsToAcquireMarketableSecurities
|
- | USD | Annual |
| Maturities of marketable securities |
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
- | USD | Annual |
| Maturities of marketable securities |
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
- | USD | Annual |
| Maturities of marketable securities |
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
- | USD | Annual |
| Maturities of marketable securities |
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
- | USD | Annual |
| Maturities of marketable securities |
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
$131.00M | USD | Annual |
| Maturities of marketable securities |
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
$131.00M | USD | Annual |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivities
|
- | USD | Annual |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivities
|
- | USD | Annual |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-225.68M | USD | Annual |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-225.68M | USD | Annual |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-13.00K | USD | Annual |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-13.00K | USD | Annual |
| Proceeds from issuance of debt, net of issuance costs |
ProceedsFromIssuanceOfLongTermDebt
|
- | USD | Annual |
| Proceeds from issuance of debt, net of issuance costs |
ProceedsFromIssuanceOfLongTermDebt
|
- | USD | Annual |
| Proceeds from issuance of debt, net of issuance costs |
ProceedsFromIssuanceOfLongTermDebt
|
$49.89M | USD | Annual |
| Proceeds from issuance of debt, net of issuance costs |
ProceedsFromIssuanceOfLongTermDebt
|
$49.89M | USD | Annual |
| Proceeds from issuance of debt, net of issuance costs |
ProceedsFromIssuanceOfLongTermDebt
|
- | USD | Annual |
| Proceeds from issuance of debt, net of issuance costs |
ProceedsFromIssuanceOfLongTermDebt
|
- | USD | Annual |
| Proceeds from the sale of common stock, net of issuance costs |
ProceedsFromIssuanceOfCommonStock
|
- | USD | Annual |
| Proceeds from the sale of common stock, net of issuance costs |
ProceedsFromIssuanceOfCommonStock
|
- | USD | Annual |
| Proceeds from the sale of common stock, net of issuance costs |
ProceedsFromIssuanceOfCommonStock
|
$148.96M | USD | Annual |
| Proceeds from the sale of common stock, net of issuance costs |
ProceedsFromIssuanceOfCommonStock
|
$148.96M | USD | Annual |
| Proceeds from the sale of common stock, net of issuance costs |
ProceedsFromIssuanceOfCommonStock
|
- | USD | Annual |
| Proceeds from the sale of common stock, net of issuance costs |
ProceedsFromIssuanceOfCommonStock
|
- | USD | Annual |
| Proceeds from the sale of common stock, common stock warrants and pre-funded stock warrants, net of issuance costs |
ProceedsFromTheSaleOfCommonStockCommonStockWarrantsAndPrefundedStockWarrantsNetOfIssuanceCosts
|
- | USD | Annual |
| Proceeds from the sale of common stock, common stock warrants and pre-funded stock warrants, net of issuance costs |
ProceedsFromTheSaleOfCommonStockCommonStockWarrantsAndPrefundedStockWarrantsNetOfIssuanceCosts
|
- | USD | Annual |
| Proceeds from the sale of common stock, common stock warrants and pre-funded stock warrants, net of issuance costs |
ProceedsFromTheSaleOfCommonStockCommonStockWarrantsAndPrefundedStockWarrantsNetOfIssuanceCosts
|
$137.86M | USD | Annual |
| Proceeds from the sale of common stock, common stock warrants and pre-funded stock warrants, net of issuance costs |
ProceedsFromTheSaleOfCommonStockCommonStockWarrantsAndPrefundedStockWarrantsNetOfIssuanceCosts
|
$137.86M | USD | Annual |
| Proceeds from the sale of common stock, common stock warrants and pre-funded stock warrants, net of issuance costs |
ProceedsFromTheSaleOfCommonStockCommonStockWarrantsAndPrefundedStockWarrantsNetOfIssuanceCosts
|
$14.11M | USD | Annual |
| Proceeds from the sale of common stock, common stock warrants and pre-funded stock warrants, net of issuance costs |
ProceedsFromTheSaleOfCommonStockCommonStockWarrantsAndPrefundedStockWarrantsNetOfIssuanceCosts
|
$14.11M | USD | Annual |
| Proceeds from exercise of common stock and pre-funded stock warrants |
ProceedsFromExerciseOfCommonStockAndPreFundedStockWarrants
|
$41.81M | USD | Annual |
| Proceeds from exercise of common stock and pre-funded stock warrants |
ProceedsFromExerciseOfCommonStockAndPreFundedStockWarrants
|
$41.81M | USD | Annual |
| Proceeds from exercise of common stock and pre-funded stock warrants |
ProceedsFromExerciseOfCommonStockAndPreFundedStockWarrants
|
$12.87M | USD | Annual |
| Proceeds from exercise of common stock and pre-funded stock warrants |
ProceedsFromExerciseOfCommonStockAndPreFundedStockWarrants
|
$12.87M | USD | Annual |
| Proceeds from exercise of common stock and pre-funded stock warrants |
ProceedsFromExerciseOfCommonStockAndPreFundedStockWarrants
|
- | USD | Annual |
| Proceeds from exercise of common stock and pre-funded stock warrants |
ProceedsFromExerciseOfCommonStockAndPreFundedStockWarrants
|
- | USD | Annual |
| Proceeds from exercise of stock options |
ProceedsFromStockOptionsExercised
|
- | USD | Annual |
| Proceeds from exercise of stock options |
ProceedsFromStockOptionsExercised
|
- | USD | Annual |
| Proceeds from exercise of stock options |
ProceedsFromStockOptionsExercised
|
$347.00K | USD | Annual |
| Proceeds from exercise of stock options |
ProceedsFromStockOptionsExercised
|
$347.00K | USD | Annual |
| Proceeds from exercise of stock options |
ProceedsFromStockOptionsExercised
|
$1.32M | USD | Annual |
| Proceeds from exercise of stock options |
ProceedsFromStockOptionsExercised
|
$1.32M | USD | Annual |
| Tax withholding payments for net share-settled equity awards |
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
- | USD | Annual |
| Tax withholding payments for net share-settled equity awards |
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
- | USD | Annual |
| Tax withholding payments for net share-settled equity awards |
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
- | USD | Annual |
| Tax withholding payments for net share-settled equity awards |
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
- | USD | Annual |
| Tax withholding payments for net share-settled equity awards |
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
$16.00K | USD | Annual |
| Tax withholding payments for net share-settled equity awards |
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
$16.00K | USD | Annual |
| Net cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$180.02M | USD | Annual |
| Net cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$180.02M | USD | Annual |
| Net cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$213.03M | USD | Annual |
| Net cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$213.03M | USD | Annual |
| Net cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$14.09M | USD | Annual |
| Net cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$14.09M | USD | Annual |
| Net increase (decrease) in cash and cash equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$-6.70M | USD | Annual |
| Net increase (decrease) in cash and cash equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$-6.70M | USD | Annual |
| Net increase (decrease) in cash and cash equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$155.08M | USD | Annual |
| Net increase (decrease) in cash and cash equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$155.08M | USD | Annual |
| Net increase (decrease) in cash and cash equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$-81.75M | USD | Annual |
| Net increase (decrease) in cash and cash equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$-81.75M | USD | Annual |
| Cash and cash equivalents, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$14.60M | USD | Point-in-time |
| Cash and cash equivalents, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$14.60M | USD | Point-in-time |
| Cash and cash equivalents, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$87.93M | USD | Point-in-time |
| Cash and cash equivalents, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$87.93M | USD | Point-in-time |
| Cash and cash equivalents, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$169.68M | USD | Point-in-time |
| Cash and cash equivalents, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$169.68M | USD | Point-in-time |
| Cash and cash equivalents, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$21.30M | USD | Point-in-time |
| Cash and cash equivalents, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$21.30M | USD | Point-in-time |
| Cash and cash equivalents, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$14.60M | USD | Point-in-time |
| Cash and cash equivalents, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$14.60M | USD | Point-in-time |
| Cash and cash equivalents, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$87.93M | USD | Point-in-time |
| Cash and cash equivalents, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$87.93M | USD | Point-in-time |
| Cash and cash equivalents, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$169.68M | USD | Point-in-time |
| Cash and cash equivalents, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$169.68M | USD | Point-in-time |
| Cash and cash equivalents, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$21.30M | USD | Point-in-time |
| Cash and cash equivalents, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$21.30M | USD | Point-in-time |
| Operating lease right-of-use assets obtained in exchange for operating lease obligations |
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
$2.83M | USD | Annual |
| Operating lease right-of-use assets obtained in exchange for operating lease obligations |
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
$2.83M | USD | Annual |
| Operating lease right-of-use assets obtained in exchange for operating lease obligations |
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
$597.00K | USD | Annual |
| Operating lease right-of-use assets obtained in exchange for operating lease obligations |
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
$597.00K | USD | Annual |
| Operating lease right-of-use assets obtained in exchange for operating lease obligations |
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
- | USD | Annual |
| Operating lease right-of-use assets obtained in exchange for operating lease obligations |
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
- | USD | Annual |
| Non-cash exercise of 2018 PIPE Warrants |
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationWarrantsExercised
|
- | USD | Annual |
| Non-cash exercise of 2018 PIPE Warrants |
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationWarrantsExercised
|
- | USD | Annual |
| Non-cash exercise of 2018 PIPE Warrants |
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationWarrantsExercised
|
$183.00K | USD | Annual |
| Non-cash exercise of 2018 PIPE Warrants |
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationWarrantsExercised
|
$183.00K | USD | Annual |
| Non-cash exercise of 2018 PIPE Warrants |
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationWarrantsExercised
|
- | USD | Annual |
| Non-cash exercise of 2018 PIPE Warrants |
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationWarrantsExercised
|
- | USD | Annual |
| Purchases of property and equipment included in accounts payable |
CapitalExpendituresIncurredButNotYetPaid
|
$1.00K | USD | Annual |
| Purchases of property and equipment included in accounts payable |
CapitalExpendituresIncurredButNotYetPaid
|
$1.00K | USD | Annual |
| Purchases of property and equipment included in accounts payable |
CapitalExpendituresIncurredButNotYetPaid
|
- | USD | Annual |
| Purchases of property and equipment included in accounts payable |
CapitalExpendituresIncurredButNotYetPaid
|
- | USD | Annual |
| Purchases of property and equipment included in accounts payable |
CapitalExpendituresIncurredButNotYetPaid
|
- | USD | Annual |
| Purchases of property and equipment included in accounts payable |
CapitalExpendituresIncurredButNotYetPaid
|
- | USD | Annual |
| Debt issuance costs included in accounts payable |
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
|
- | USD | Annual |
| Debt issuance costs included in accounts payable |
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
|
- | USD | Annual |
| Debt issuance costs included in accounts payable |
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
|
- | USD | Annual |
| Debt issuance costs included in accounts payable |
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
|
- | USD | Annual |
| Debt issuance costs included in accounts payable |
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
|
$62.00K | USD | Annual |
| Debt issuance costs included in accounts payable |
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
|
$62.00K | USD | Annual |
Stockholders Equity
50 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Balances at beginning |
StockholdersEquity
|
$17.79M | USD | Point-in-time |
| Balances at beginning |
StockholdersEquity
|
$17.79M | USD | Point-in-time |
| Balances at beginning |
StockholdersEquity
|
$157.51M | USD | Point-in-time |
| Balances at beginning |
StockholdersEquity
|
$157.51M | USD | Point-in-time |
| Less transaction costs |
PaymentsOfStockIssuanceCosts
|
$8.45M | USD | Annual |
| Less transaction costs |
PaymentsOfStockIssuanceCosts
|
$8.45M | USD | Annual |
| Balances at beginning |
StockholdersEquity
|
$10.35M | USD | Point-in-time |
| Balances at beginning |
StockholdersEquity
|
$10.35M | USD | Point-in-time |
| Balances at beginning |
StockholdersEquity
|
$245.11M | USD | Point-in-time |
| Balances at beginning |
StockholdersEquity
|
$245.11M | USD | Point-in-time |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$2.53M | USD | Annual |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$2.53M | USD | Annual |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$5.81M | USD | Annual |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$5.81M | USD | Annual |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$99.96M | USD | Annual |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$99.96M | USD | Annual |
| Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units |
StockIssuedDuringPeriodValueStockOptionsExerciseAndRestricedStockAwardsVesting
|
$1.32M | USD | Annual |
| Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units |
StockIssuedDuringPeriodValueStockOptionsExerciseAndRestricedStockAwardsVesting
|
$1.32M | USD | Annual |
| Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units |
StockIssuedDuringPeriodValueStockOptionsExerciseAndRestricedStockAwardsVesting
|
$483.00K | USD | Annual |
| Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units |
StockIssuedDuringPeriodValueStockOptionsExerciseAndRestricedStockAwardsVesting
|
$483.00K | USD | Annual |
| Tax withholding payments for net share-settled equity awards |
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
$16.00K | USD | Annual |
| Tax withholding payments for net share-settled equity awards |
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
$16.00K | USD | Annual |
| Sale of common stock, net of issuance costs |
StockIssuedDuringPeriodValueNewIssues
|
$148.96M | USD | Annual |
| Sale of common stock, net of issuance costs |
StockIssuedDuringPeriodValueNewIssues
|
$148.96M | USD | Annual |
| Sale of common stock, net of issuance costs |
StockIssuedDuringPeriodValueNewIssues
|
$342.00K | USD | Annual |
| Sale of common stock, net of issuance costs |
StockIssuedDuringPeriodValueNewIssues
|
$342.00K | USD | Annual |
| Sale of common stock and issuance of common stock warrants and pre-funded common stock warrants, net of issuance costs |
StockAndWarrantsIssuedDuringPeriodValueNewIssues
|
$137.86M | USD | Annual |
| Sale of common stock and issuance of common stock warrants and pre-funded common stock warrants, net of issuance costs |
StockAndWarrantsIssuedDuringPeriodValueNewIssues
|
$137.86M | USD | Annual |
| Sale of pre-funded warrants in public offering, net of issuance costs |
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
$4.44M | USD | Annual |
| Sale of pre-funded warrants in public offering, net of issuance costs |
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
$4.44M | USD | Annual |
| Exercise of common stock warrants |
ExerciseOfCommonStockWarrants
|
$42.00M | USD | Annual |
| Exercise of common stock warrants |
ExerciseOfCommonStockWarrants
|
$42.00M | USD | Annual |
| Exercise of common stock warrants and pre-funded common stock warrants |
StockIssuedDuringPeriodValueExerciseOfCommonStockWarrantsAndPreFundedCommonStockWarrants
|
$12.87M | USD | Annual |
| Exercise of common stock warrants and pre-funded common stock warrants |
StockIssuedDuringPeriodValueExerciseOfCommonStockWarrantsAndPreFundedCommonStockWarrants
|
$12.87M | USD | Annual |
| Unrealized gain on marketable securities |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$361.00K | USD | Annual |
| Unrealized gain on marketable securities |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$361.00K | USD | Annual |
| Net Income (Loss) |
NetIncomeLoss
|
$-175.85M | USD | Annual |
| Net Income (Loss) |
NetIncomeLoss
|
$-175.85M | USD | Annual |
| Net Income (Loss) |
NetIncomeLoss
|
$-24.07M | USD | Annual |
| Net Income (Loss) |
NetIncomeLoss
|
$-24.07M | USD | Annual |
| Net Income (Loss) |
NetIncomeLoss
|
$-38.99M | USD | Annual |
| Net Income (Loss) |
NetIncomeLoss
|
$-38.99M | USD | Annual |
| Balances at ending |
StockholdersEquity
|
$17.79M | USD | Point-in-time |
| Balances at ending |
StockholdersEquity
|
$17.79M | USD | Point-in-time |
| Balances at ending |
StockholdersEquity
|
$157.51M | USD | Point-in-time |
| Balances at ending |
StockholdersEquity
|
$157.51M | USD | Point-in-time |
| Balances at ending |
StockholdersEquity
|
$10.35M | USD | Point-in-time |
| Balances at ending |
StockholdersEquity
|
$10.35M | USD | Point-in-time |
| Balances at ending |
StockholdersEquity
|
$245.11M | USD | Point-in-time |
| Balances at ending |
StockholdersEquity
|
$245.11M | USD | Point-in-time |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.